Clinical Trials in Salt Lake City

Showing 12601-12620 of 16,694 trials

Safety and Pharmacokinetics of Ifetroban in Hepatorenal Syndrome Patients

NCT01436500

A study of ifetroban in the treatment of hepatorenal syndrome (HRS) in hospitalized adult patients to assess the safety and pharmacokinetics of 3 days of intravenous ifetroban.

Hepatorenal Syndrome

Cumberland Pharmaceuticals55 participantsStarted Oct 2011

Phoenix, Arizona, United States • La Jolla, California, United States • San Francisco, California, United States +9 more locations

TERMINATEDPhase 1< 1 mile

Ipilimumab and Dabrafenib in the 1st Line Tx of Unresectable Stage III/IV Melanoma

NCT02200562

Phase I/II study of ipilimumab concurrent ipilimumab and dabrafenib as first line treatment in Stage III or IV melanoma. Assessing safety of Ipilimumab and dabrafenib in combination. Also, assessing disease control rates.

Stage III or IV Melanoma

University of Utah6 participantsStarted Dec 2014

Salt Lake City, Utah, United States

COMPLETEDNA< 1 mile

Cancer & Chemotherapy Symptom Management Using an Automated Telephone Reporting System

NCT01979146

The purpose of this study was to test the efficacy of a computer-based automated symptom monitoring telephone system used by patients who received chemotherapy for their cancer to communicate unrelieved symptoms they experienced to their oncology providers.

Cancer

University of Utah250 participantsStarted Apr 2001

Boston, Massachusetts, United States • Greer, South Carolina, United States • Salt Lake City, Utah, United States

Safety and Pharmacokinetics of Ifetroban in Hepatorenal Syndrome Patients

Ipilimumab and Dabrafenib in the 1st Line Tx of Unresectable Stage III/IV Melanoma

Cancer & Chemotherapy Symptom Management Using an Automated Telephone Reporting System

Find Trials by Condition in Salt Lake City

Comparison of Two NN1250 Formulations Versus Insulin Glargine, All in Combination With Metformin in Subjects With Type 2 Diabetes

Comparison of Two NN1250 Formulations Versus Insulin Glargine, All in Combination With Insulin Aspart in Subjects With Type 1 Diabetes

Efficacy and Safety Study of Oral Solithromycin (CEM-101) Compared to Oral Moxifloxacin in Treatment of Patients With Community-Acquired Bacterial Pneumonia

YouScript IMPACT Registry

Assessing the Engagement of Transgender and Other Gender Minority Youth Across the HIV Continuum of Care

Evaluation of Modified Treatment Regimens for Treatment of Heavy Menstrual Bleeding Using the HerOption® System

PHASES: Provision of HIV Treatment at ATN Sites: An Evaluation for Stakeholders

4-Day-A-Week Treatment Plan for HIV Infected Adolescents

A Novel Method to Determine HIV Incidence Among Youth

Identifying Undiagnosed Asymptomatic HIV Infection in Hispanic/Latino Adolescents and Young Adults

HIV Treatment-Readiness Measure (HTRM) Validation

C2P Mobilization Intervention (Pilot)

CDC-ATN Linkage Evaluation

AVERT™ Clinical Trial for Contrast Media Volume Reduction and Incidence of CIN

Safety and Efficacy of Somatropin in Children With Growth Hormone Deficiency

A Phase I Single Ascending Dose Study of the Intravitreal Plasma Kallikrein Inhibitor KVD001 in Subjects With DME

EPO906 in Carcinoid and Other Neuroendocrine Tumors